Image source: © 2025 Krish Capital Pty. Ltd.

Highlights:

  • BUY ratings from Investec and Berenberg imply up to 43.3% upside.

  • FY25 adjusted PBT margin improves to 27% amid 11% growth in ongoing business revenue.

  • WIL's cash generation supports acquisitions and shareholder returns.

Wilmington plc (LSE:WIL), a key provider of data, information, education, and training services in the Governance, Risk, and Compliance (GRC) space, has received BUY recommendations from multiple analysts. The rating is likely to be backed by its FY25 trading update and operating performance.

Analysts Back Wilmington’s Growth Strategy

Analysts from Investec Bank and Berenberg have issued BUY ratings, citing Wilmington’s operational resilience, strategic acquisitions, and margin expansion. Berenberg’s James Fletcher has set a target price of AUD 9.41, reflecting a 43.3% upside from current levels. Similarly, Investec’s Alastair P. Reid maintained a BUY call with a target price of AUD 9.21, offering a 40.19% potential gain.

The consensus current target price stands at AUD 9.17, up from the current price of GBP 321p (AUD 6.56), showing a weighted implied upside of nearly 39.7%. 

FY25 Trading Update 

For the financial year ended 30 June 2025, Wilmington expects revenue from ongoing businesses to grow by 11%, led by double-digit growth in newly acquired Health, Safety, and Environment (HSE) sector entities. This performance offset challenges in the U.S. healthcare insurance market, which impacted event revenues and resulted in a modest 1% organic revenue decline.

Despite these headwinds, operating profit from ongoing businesses is projected to rise 11%, with adjusted profit before tax (PBT) expected at £27.7 million, marginally higher than FY24’s £27.6 million. More importantly, the Group's adjusted PBT margin improved substantially to 27%, up from 22%, reflecting efficient cost management and margin discipline.

Strategic Investments and Capital Returns Continue

Wilmington ended FY25 with net cash of £41.9 million, even after significant capital deployment. This includes the acquisition of Phoenix Health & Safety completed in October 2024 and £3.4 million in share buybacks with the Group’s cash conversion of 107%.

With seven of nine businesses posting year-on-year growth at the half-year mark, momentum across core segments remains positive.

The Group prepares to release its full FY25 results on 22 September 2025..